Dave Wendland, vice president of strategic relations at Hamacher Resource Group, discusses how OTC manufacturers are becoming more intentional with their new product launches.
Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease.